UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city

Revista de saúde pública, 2017-01, Vol.51, p.59-59

2017

Link zum Volltext

Verfügbarkeit prüfen

Fees-for-services, cost recovery, and equity in a district of Burkina Faso operating the Bamako initiative

Bulletin of the World Health Organization, 2003-01, Vol.81 (7), p.532-538

RIDDE, Valery

2003

Link zum Volltext

Verfügbarkeit prüfen

Brazilian generics market change after Farmácia Popular program

Revista de saúde pública, 2019-01, Vol.53, p.94-94

2019

Link zum Volltext

Verfügbarkeit prüfen

Perception of the value of generic drugs in São Paulo, Brazil

Cadernos de saúde pública, 2016-01, Vol.32 (2), p.e00038715-e00038715

2016

Link zum Volltext

Verfügbarkeit prüfen

How much does the backlog on drug patents cost for health in Brazil?

Cadernos de saúde pública, 2017-08, Vol.33 (8), p.e00206516-e00206516

2017

Link zum Volltext

Verfügbarkeit prüfen

The impact of the Medicines Control Council backlog and fast-track review system on access to innovative and new generic and biosimilar medicines of public health importance in South Africa

SAMJ: South African Medical Journal, 2016-04, Vol.106 (4), p.43-46

2016

Link zum Volltext

Verfügbarkeit prüfen

Affordability and availability of drugs for treatment of chronic diseases in the public health care system

Revista panamericana de salud pública, 2012-03, Vol.31 (3), p.225-232

2012

Link zum Volltext

Verfügbarkeit prüfen

Procurement of generic medicines in a medium size municipality

Revista de saúde pública, 2011-06, Vol.45 (3), p.583-589

2011

Link zum Volltext

Verfügbarkeit prüfen

Medicine prices and availability in the Brazilian Popular Pharmacy Program

Revista de saúde pública, 2010-08, Vol.44 (4), p.611-619

2010

Link zum Volltext

Verfügbarkeit prüfen

Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology

Revista panamericana de salud pública, 2010-04, Vol.27 (4), p.291-299

2010

Link zum Volltext

Verfügbarkeit prüfen

Availability of generic drugs in the public sector and prices in the private sector in different regions of Brazil

Cadernos de saúde pública, 2009-10, Vol.25 (10), p.2147-2158

2009

Link zum Volltext

Verfügbarkeit prüfen

Generic drugs in Brazil: known by many, used by few

Cadernos de saúde pública, 2005-12, Vol.21 (6), p.1808-1815

2005

Link zum Volltext

Verfügbarkeit prüfen

International drug price comparisons: quality assessment

Revista panamericana de salud pública, 2011-01, Vol.29 (1), p.46-51

2011

Link zum Volltext

Verfügbarkeit prüfen

Cost of drugs used to treat cardiovascular disease in Brazil

Revista panamericana de salud pública, 2012-01, Vol.31 (1), p.62-67

2012

Link zum Volltext

Verfügbarkeit prüfen

Diferenças de preços entre medicamentos genéricos e de referência no Brasil

Revista de saúde pública, 2006-06, Vol.40 (3), p.444-449

2006

Link zum Volltext

Verfügbarkeit prüfen

Price differences between generic and innovator medicines in Brazil

Revista de saúde pública, 2006-06, Vol.40 (3), p.444-449

2006

Link zum Volltext

Verfügbarkeit prüfen

The paradigm of stains: will the lower cost of generics translate into health gains?

Revista portuguesa de cardiologia, 2007-05, Vol.26 (5), p.497-501

Seabra-Gomes, Ricardo

2007

Link zum Volltext

Verfügbarkeit prüfen

Economic impact of eyedrop cost in glaucoma treatment

Arquivos brasileiros de oftalmologia, 2005-01, Vol.68 (1), p.79-84

2005

Link zum Volltext

Verfügbarkeit prüfen

Overpricing and affordability of drugs: the case of essential drugs in Mexico

Cadernos de saúde pública, 1998-07, Vol.14 (3), p.501-506

1998

Link zum Volltext

Verfügbarkeit prüfen

Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira

Gestão & Produção, 2012, Vol.19 (2), p.405-418

2012

Link zum Volltext

Verfügbarkeit prüfen

Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira Changing technology strategies: a study of brazilian pharmaceutical industry

Gestão & produção, 2012-01, Vol.19 (2), p.405-418

2012

Link zum Volltext

Verfügbarkeit prüfen

Access to hepatitis C medicines

Bulletin of the World Health Organization, 2015-11, Vol.93 (11), p.799-805

2015

Link zum Volltext

Verfügbarkeit prüfen

Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform

Bulletin of the World Health Organization, 2015-09, Vol.93 (9), p.606-613

2015

Link zum Volltext

Verfügbarkeit prüfen

Acceso a medicamentos y situación del mercado farmacéutico en Ecuador

Revista panamericana de salud pública, 2014-07, Vol.36 (1), p.57-62

2014

Link zum Volltext

Verfügbarkeit prüfen

Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?

Bulletin of the World Health Organization, 2004-11, Vol.82 (11), p.815-821

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(50)
Dissertationen
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Public, Environmental & Occupational Health
(28)
Humans
(27)
Brazil
(20)
Generic Drugs
(19)
Health Policy & Services
(19)
Drugs, Generic - Economics
(17)
Pharmaceutical Industry
(14)
Drugs
(12)
Economics
(12)
Socioeconomic Factors
(10)
Drugs, Generic - Therapeutic Use
(8)
Female
(8)
Male
(8)
Cross-Sectional Studies
(7)
Middle Aged
(7)
Public Health
(7)
Adult
(6)
Biological And Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city

Fees-for-services, cost recovery, and equity in a district of Burkina Faso operating the Bamako initiative

Brazilian generics market change after Farmácia Popular program

Perception of the value of generic drugs in São Paulo, Brazil

How much does the backlog on drug patents cost for health in Brazil?

The impact of the Medicines Control Council backlog and fast-track review system on access to innovative and new generic and biosimilar medicines of public health importance in South Africa

Affordability and availability of drugs for treatment of chronic diseases in the public health care system

Procurement of generic medicines in a medium size municipality

Medicine prices and availability in the Brazilian Popular Pharmacy Program

Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology

Availability of generic drugs in the public sector and prices in the private sector in different regions of Brazil

Generic drugs in Brazil: known by many, used by few

International drug price comparisons: quality assessment

Cost of drugs used to treat cardiovascular disease in Brazil

Diferenças de preços entre medicamentos genéricos e de referência no Brasil

Price differences between generic and innovator medicines in Brazil

The paradigm of stains: will the lower cost of generics translate into health gains?

Economic impact of eyedrop cost in glaucoma treatment

Overpricing and affordability of drugs: the case of essential drugs in Mexico

Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira

Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira Changing technology strategies: a study of brazilian pharmaceutical industry

Access to hepatitis C medicines

Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform

Acceso a medicamentos y situación del mercado farmacéutico en Ecuador

Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?

Aktive Filter

Suchergebnisse filtern